Last reviewed · How we verify
E. Coli Pelvic Cellulitis
Approved treatments
- Claforan · Sterimax
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Noroxin
- Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- E. Coli Pelvic Cellulitis patent landscape — cliff calendar, originator estates, attackable patents
- E. Coli Pelvic Cellulitis treatment landscape brief
- E. Coli Pelvic Cellulitis treatment updates RSS
Frequently asked questions about E. Coli Pelvic Cellulitis
What drugs treat E. Coli Pelvic Cellulitis?
Tracked treatments include Claforan, Fortaz, Mefoxin In Sodium Chloride 0.9% In Plastic Container, Noroxin, Ceftazidim.
What is the treatment for E. Coli Pelvic Cellulitis?
Standard treatment for E. Coli Pelvic Cellulitis includes Claforan, Fortaz, Mefoxin In Sodium Chloride 0.9% In Plastic Container, Noroxin, Ceftazidim. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: E. Coli Pelvic Cellulitis patent cliff · E. Coli Pelvic Cellulitis CI report
- Treatment: Claforan · Sterimax
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Noroxin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing